This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEC0L0PD_M.jpg
Orbimed Capital’s holding in Arcutis Biotherapeutics, Inc. increased to about 902 thousand shares with the purchase.
Orbimed Capital increased stake in Arcutis Biotherapeutics, Inc.
4 years ago
No Comments
Related Posts
S&P 500 Rides Meta Rally Higher as Tech Flexes Muscles
April 28, 2022
Speculators' bearish bets on U.S. dollar rise: CFTC, Reuters data
June 12, 2020
Asia stocks, oil struggle as Omicron worries weigh
December 27, 2021
Allegro Funds gets final regulatory approval to take over PwC Australia spinoff
November 6, 2023
Starbucks Rises as Stifel Sees Management Making The Right Moves
August 25, 2020
Why Zscaler Shares are Trading Lower Today
October 11, 2022
About The Author
